Manufacturing Policy

Transparency is just one of the reasons to reshore pharmaceutical manufacturing, witnesses tell Senate special committee.

A U.S. Senate panel this week will take a close look at security of our pharmaceutical supply chains.

Industry and labor leaders expected to discuss their legislative and policy priorities in a Wednesday hearing.

Reflections from 2025's California Economic Summit in Stockton.

Manufacturing prowess is "the hinge on which history turns," and much of it's taking place outside the United States, a panelist argues.

The National Manufacturing Advisory Council Act, which passed the U.S. Senate unanimously, is the latest example.

The legislative effort would be a major step toward reshoring production capacity for an important industry.

The CEO of Guardian Bikes details the challenges an industry whose production has moved almost entirely offshore.

A tariff reprieve won’t help – but it will take far more than tariffs, anyway. Smartphones, computers and other electronics got an exclusion from the suddenly very high “reciprocal”...

President-elect Donald Trump has said that he plans to repeal the Inflation Reduction Act, but doing so would imperil the thousands of new factory jobs that are set to grow in Republican districts.